Electromed, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Electromed, Inc. (ELMD) reported Revenue from Contract with Customer, Excluding Assessed Tax of $73.78 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-25.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-25
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $19.42M, a 11.64% increase year-over-year.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $18.57M, a 18.43% increase year-over-year.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $18.90M, a 16.25% increase year-over-year.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $16.89M, a 15.13% increase year-over-year.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2026 was $73.78M, a 15.27% increase from fiscal 2025.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $64.00M, a 16.97% increase from fiscal 2024.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $54.72M, a 13.83% increase from fiscal 2023.
- Electromed, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $48.07M, a 15.38% increase from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | $37.99M derived: sum of 2 quarters · filed 2026-08-25 | $56.89M derived: sum of 3 quarters · filed 2026-08-25 | $73.78M 10-K · filed 2026-08-25 | ||||
| 2026-03-31 | $18.57M 10-Q · filed 2026-05-12 | $37.47M derived: sum of 2 quarters · filed 2026-05-12 | $54.36M 10-Q · filed 2026-05-12 | $71.75M derived: sum of 4 quarters · filed 2026-08-25 | ||||
| 2025-12-31 | $18.90M 10-Q · filed 2026-02-10 | $35.78M 10-Q · filed 2026-02-10 | $53.18M derived: sum of 3 quarters · filed 2026-08-25 | $68.86M derived: sum of 4 quarters · filed 2026-08-25 | ||||
| 2025-09-30 | $16.89M 10-Q · filed 2025-11-12 | $34.28M derived: sum of 2 quarters · filed 2026-08-25 | $49.96M derived: sum of 3 quarters · filed 2026-08-25 | $66.22M derived: sum of 4 quarters · filed 2026-08-25 | ||||
| 2025-06-30 | $17.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | $33.08M derived: sum of 2 quarters · filed 2026-08-25 | $49.33M derived: sum of 3 quarters · filed 2026-08-25 | $64.00M 10-K · filed 2026-08-25 | ||||
| 2025-03-31 | $15.68M 10-Q · filed 2026-05-12 | $31.94M derived: sum of 2 quarters · filed 2026-05-12 | $46.61M 10-Q · filed 2026-05-12 | $61.44M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $16.25M 10-Q · filed 2026-02-10 | $30.92M 10-Q · filed 2026-02-10 | $45.76M derived: sum of 3 quarters · filed 2026-02-10 | $59.63M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-09-30 | $14.67M 10-Q · filed 2025-11-12 | $29.50M derived: sum of 2 quarters · filed 2025-11-12 | $43.37M derived: sum of 3 quarters · filed 2025-11-12 | $57.06M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $14.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-26 | $28.70M derived: sum of 2 quarters · filed 2025-08-26 | $42.39M derived: sum of 3 quarters · filed 2025-08-26 | $54.72M 10-K · filed 2025-08-26 | ||||
| 2024-03-31 | $13.87M 10-Q · filed 2025-05-13 | $27.56M derived: sum of 2 quarters · filed 2025-05-13 | $39.88M 10-Q · filed 2025-05-13 | $53.50M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $13.69M 10-Q · filed 2025-02-11 | $26.01M 10-Q · filed 2025-02-11 | $39.63M derived: sum of 3 quarters · filed 2025-02-11 | $51.69M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-09-30 | $12.32M 10-Q · filed 2024-11-12 | $25.94M derived: sum of 2 quarters · filed 2024-11-12 | $38.00M derived: sum of 3 quarters · filed 2024-11-12 | $49.73M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $13.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-27 | $25.68M derived: sum of 2 quarters · filed 2024-08-27 | $37.41M derived: sum of 3 quarters · filed 2024-08-27 | $48.07M 10-K · filed 2024-08-27 | ||||
| 2023-03-31 | $12.07M 10-Q · filed 2024-05-07 | $23.80M derived: sum of 2 quarters · filed 2024-05-07 | $34.45M 10-Q · filed 2024-05-07 | $45.72M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $11.73M 10-Q · filed 2024-02-13 | $22.39M 10-Q · filed 2024-02-13 | $33.66M derived: sum of 3 quarters · filed 2024-02-13 | $43.80M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-09-30 | $10.66M 10-Q · filed 2023-11-07 | $21.93M derived: sum of 2 quarters · filed 2023-11-07 | $32.07M derived: sum of 3 quarters · filed 2023-11-07 | $42.32M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $11.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-22 | $21.41M derived: sum of 2 quarters · filed 2023-08-22 | $31.66M derived: sum of 3 quarters · filed 2023-08-22 | $41.66M 10-K · filed 2023-08-22 | ||||
| 2022-03-31 | $10.14M 10-Q · filed 2023-05-09 | $20.39M derived: sum of 2 quarters · filed 2023-05-09 | $30.39M 10-Q · filed 2023-05-09 | $39.86M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $10.25M 10-Q · filed 2023-02-14 | $20.25M 10-Q · filed 2023-02-14 | $29.72M derived: sum of 3 quarters · filed 2023-02-14 | $38.51M derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $10.00M 10-Q · filed 2022-11-08 | $19.47M derived: sum of 2 quarters · filed 2022-11-08 | $28.26M derived: sum of 3 quarters · filed 2022-11-08 | $37.75M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $18.26M derived: sum of 2 quarters · filed 2022-08-23 | $27.75M derived: sum of 3 quarters · filed 2022-08-23 | $35.76M 10-K · filed 2022-08-23 | ||||
| 2021-03-31 | $8.79M 10-Q · filed 2022-05-10 | $8.79M 10-Q · filed 2021-05-11 | $18.28M derived: sum of 2 quarters · filed 2022-05-10 | $26.29M 10-Q · filed 2022-05-10 | $26.29M 10-Q · filed 2021-05-11 | $33.16M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $9.50M 10-Q · filed 2022-02-08 | $9.50M 10-Q · filed 2021-02-09 | $17.50M 10-Q · filed 2022-02-08 | $17.50M 10-Q · filed 2021-02-09 | $24.38M derived: sum of 3 quarters · filed 2022-02-08 | $33.12M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2020-09-30 | $8.00M 10-Q · filed 2021-11-09 | $14.88M derived: sum of 2 quarters · filed 2021-11-09 | $23.63M derived: sum of 3 quarters · filed 2021-11-09 | $32.17M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-24 | $15.62M derived: sum of 2 quarters · filed 2021-08-24 | $24.17M derived: sum of 3 quarters · filed 2021-08-24 | $32.47M 10-K · filed 2021-08-24 | $32.47M 10-K · filed 2020-08-25 | |||
| 2020-03-31 | $8.74M 10-Q · filed 2021-05-11 | $17.29M derived: sum of 2 quarters · filed 2021-05-11 | $25.59M 10-Q · filed 2021-05-11 | $34.20M derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $8.55M 10-Q · filed 2021-02-09 | $16.85M 10-Q · filed 2021-02-09 | $25.45M derived: sum of 3 quarters · filed 2021-02-09 | $32.86M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-09-30 | $8.30M 10-Q · filed 2020-11-10 | $8.30M 10-Q · filed 2019-11-12 | $16.91M derived: sum of 2 quarters · filed 2020-11-10 | $24.31M derived: sum of 3 quarters · filed 2020-11-10 | $32.33M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-25 | $16.01M derived: sum of 2 quarters · filed 2020-08-25 | $24.02M derived: sum of 3 quarters · filed 2020-08-25 | $31.30M 10-K · filed 2020-08-25 | ||||
| 2019-03-31 | $7.41M 10-Q · filed 2020-05-12 | $15.42M derived: sum of 2 quarters · filed 2020-05-12 | $22.70M 10-Q · filed 2020-05-12 | $30.57M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $8.01M 10-Q · filed 2020-02-11 | $15.29M 10-Q · filed 2020-02-11 | $23.16M derived: sum of 3 quarters · filed 2020-02-11 | $30.33M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-09-30 | $7.28M 10-Q · filed 2019-11-12 | $15.15M derived: sum of 2 quarters · filed 2019-11-12 | $22.32M derived: sum of 3 quarters · filed 2019-11-12 | $29.28M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-27 | $15.04M derived: sum of 2 quarters · filed 2019-08-27 | $22.00M derived: sum of 3 quarters · filed 2019-08-27 | $28.31M 10-K · filed 2019-08-27 | ||||
| 2018-03-31 | $7.17M 10-Q · filed 2019-05-07 | $14.13M derived: sum of 2 quarters · filed 2019-05-07 | $20.43M 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | $6.96M 10-Q · filed 2019-02-12 | $13.27M 10-Q · filed 2019-02-12 | ||||||
| 2017-09-30 | $6.30M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |